Pfizer Recalls Anti-Smoking Drug Chantix Due to Potential Cancer Risk, While FDA Seeks ‘Options To Mitigate Shortage’; What You Need to Know About NDMA

Pfizer Recalls Anti-Smoking Drug Chantix Due to Potential Cancer Risk, While FDA Seeks ‘Options To Mitigate Shortage’; What You Need to Know About NDMA

NOW
PLAYING
New Hope For Some Early-Stage Breast Cancer Patients: FDA Approves Targeted Therapy Drug Verzenio
NOW
PLAYING
Athlete's Foot Sprays Tinactin and Lotramin Recalled For Benzene
NOW
PLAYING
5 Tips on How to Use Cannabis For Cancer
NOW
PLAYING
What Are the Side Effects of Immunotherapy for Bladder Cancer?
NOW
PLAYING
ENHERTU Is A 'Big Game Changer' for HER2 Positive Metastatic Breast Cancer Patients
NOW
PLAYING
Pfizer Issues Nationwide Recall of Anti-Smoking Drug Chantix

SurvivorNetTV.
Hope. Science.
Inspiration.

WATCH NOW
×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.